# EXPONENT INC (EXPO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from EXPONENT INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2026 MD&A](/company/EXPO/mda/fy2026/): filed 2026-02-27; accession 0001193125-26-082508 (https://www.sec.gov/Archives/edgar/data/851520/000119312526082508/expo-20260102.htm); latest 10-K
- [FY 2025 MD&A](/company/EXPO/mda/fy2025/): filed 2025-02-28; accession 0000950170-25-030001 (https://www.sec.gov/Archives/edgar/data/851520/000095017025030001/expo-20250103.htm)
- [FY 2023 MD&A](/company/EXPO/mda/fy2023/): filed 2024-02-23; accession 0000950170-24-019390 (https://www.sec.gov/Archives/edgar/data/851520/000095017024019390/expo-20231229.htm)
- [FY 2022 MD&A](/company/EXPO/mda/fy2022/): filed 2023-02-24; accession 0000950170-23-004401 (https://www.sec.gov/Archives/edgar/data/851520/000095017023004401/expo-20221230.htm)
- [FY 2021 MD&A](/company/EXPO/mda/fy2021/): filed 2022-02-25; accession 0001564590-22-007169 (https://www.sec.gov/Archives/edgar/data/851520/000156459022007169/expo-10k_20211231.htm)

Back to /company/EXPO/